0001213900-14-003956.txt : 20140604 0001213900-14-003956.hdr.sgml : 20140604 20140604112334 ACCESSION NUMBER: 0001213900-14-003956 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140604 DATE AS OF CHANGE: 20140604 EFFECTIVENESS DATE: 20140604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAMP NINE, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: [3949] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-218540 FILM NUMBER: 14889697 BUSINESS ADDRESS: STREET 1: 546 FIFTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-702-7163 MAIL ADDRESS: STREET 1: 546 FIFTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D 1 primary_doc.xml X0707 D LIVE 0001553643 CAMP NINE, INC. 546 FIFTH AVENUE 14TH FLOOR NEW YORK NY NEW YORK 10036 (212) 702-7163 NEVADA None None Corporation true 2012 Sergio Traversa 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Executive Officer Director Chief Executive Officer Eliseo O. Salinas 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Executive Officer President and Chief Scientific Officer Douglas Beck 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Executive Officer Chief Financial Officer Sandesh Seth 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Director Lead Director Shreeram Agharkar 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Director Nabil M. Yazgi 546 Fifth Avenue 14th Floor New York NY NEW YORK 10036 Director Biotechnology No Revenues 06b false 2014-05-20 false true true true Share Exchange 0 0 0 0 Shares of Relmada Therapeutics, Inc. ("Relmada") stock, representing approximately 94% of the issued and outstanding common stock of Relmada, were exchanged for Camp Nine, Inc. common stock. false 382 0 0 0 false CAMP NINE, INC. /s/ Sergio Traversa Sergio Traversa Chief Executive Officer 2014-06-03